MiMedx Group (MDXG) Financials

$4.57

$0.14 (3.16%)

As on 04-Sep-2026 16:01EDT

Market cap

$666 Mln

Revenue (TTM)

$355 Mln

P/E Ratio

114.3

P/B Ratio

3.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	355.17	418.63	348.88	321.48	267.84	242.02
Cost of Revenue	75.12	73.01	60.07	54.63	48.32	39.63
Gross Profit	280.05	345.62	288.81	266.84	219.53	202.39
Operating Expenses	271.17	281.29	229.94	229.73	234.25	209.44
Operating Profit (EBIT)	8.75	63.89	58.87	37.12	-14.73	-7.05
Other Income	--	--	--	--	--	-0.02
Profit before Tax	11.53	66.26	57.29	30.63	-19.75	-12.05
Provision for Tax	5.30	17.68	15.30	-36.81	0.21	0.25
Profit after Tax (Net Income)	6.24	48.58	42.42	67.44	-30.20	-12.30
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-36.78	-10.29

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	216.00	256.55	193.11	142.72	74.51	92.58
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	26.50	21.84	25.21	50.32	53.37	53.00
Current Liabilities	38.50	64.27	45.60	46.01	43.56	42.36
Total Liabilities	319.50	342.65	263.92	239.05	171.43	187.93

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	75.63	65.18	72.03	74.79	37.23	39.41
Current Assets	205.37	277.47	191.89	164.26	134.20	148.52
Total Assets	319.50	342.65	263.92	239.05	171.43	187.93
Total Debt*	1.50	22.53	24.84	48.10	52.47	53.29
Net Current Assets	166.87	213.21	146.29	118.25	90.64	106.17

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	74.00	66.20	26.78	-17.89	-1.98
Cash Flow from Investing Activities	--	-6.89	-9.58	-2.16	-2.66	-3.40
Cash from Financing Activities	--	-5.41	-34.20	-8.57	-0.58	-3.35
Net Cash Inflow / Outflow	--	--	--	--	--	-8.73

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	0.04	0.32	0.28	0.46	-0.27	-0.11
Cash EPS ($)	0.04	0.42	0.33	0.48	-0.23	-0.06
Adjusted Book Value ($)	1.48	1.71	1.30	0.96	0.66	0.82
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	0.49	0.44	0.18	-0.16	-0.02
Free Cash Flow per Share ($)	--	0.49	0.43	0.17	-0.18	-0.05

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	19.55	20.75	42.44	-22.13	-8.51
ROE (%)	2.64	21.61	25.26	62.09	-36.15	-13.37
ROA (%)	1.89	16.02	16.87	32.86	-16.81	-6.31
EBIT Margin (%)	3.39	16.25	17.00	11.54	-5.50	-2.92
Net Margin (%)	1.76	11.60	12.16	20.98	-11.27	-5.08
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-2.36	0.20	0.09	0.20	0.11	-0.03
EBIT Growth (%)	-73.36	14.73	59.91	351.78	-108.24	84.06
Net Profit Growth (%)	-80.61	14.52	-37.10	323.33	-145.48	75.04
EPS Growth (%)	-81.58	0.14	-0.38	2.71	-1.44	0.76
Book Value Growth (%)	0.74	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	114.25	20.87	33.80	19.26	-10.47	-55.58
Price / Book Value	3.07	3.95	7.43	9.10	4.24	7.38
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	26.68	10.49	20.72	31.21	-28.31	-343.65
Close Price ($)	3.85	6.77	9.62	8.77	2.78	6.04
High Price ($)	7.99	9.71	10.14	9.27	6.35	15.99
Low Price ($)	3.03	5.79	5.47	2.72	2.43	5.30
Market Cap ($ Cr)	666.13	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	0.07	0.09	0.13	0.34	0.70	0.58
Short term debt to equity ratio	0.01	0.01	0.01	0.01	0.02	0.01
Current Ratio	5.33	4.32	4.21	3.57	3.08	3.51
Quick Ratio	4.79	3.92	3.69	3.11	2.78	3.24
Interest Coverage	8.24	38.16	58.96	5.74	-2.94	-1.42

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	11.63	18.08	16.00	16.76	16.09	16.67
Asset Turnover	1.07	1.38	1.39	1.57	1.49	1.24
Receivable days	--	57.38	57.42	55.08	56.89	57.18
Inventory Days	--	122.93	136.28	114.33	92.88	100.23
Payable days	--	54.87	50.03	58.50	59.87	74.43
Cash Conversion Cycle	--	125.44	143.67	110.91	89.90	82.99

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.